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Nitric oxide (NO) is the most important relaxant neuro-
transmitter in the gastric fundus. The principal target of
NO is soluble guanylate cyclase (sGC). As the α1β1 iso-
form is most abundant in the gastrointestinal tract, the
aim of this study was to investigate the role of sGC in NO-
induced smooth muscle effects of gastric fundus using
wild type (WT) and sGCα1 knock-out (KO) mice of both
sexes (8–50 weeks old). Circular muscle strips of the gas-
tric fundus were precontracted with prostaglandin F2α
(PGF2α) in the presence of atropine and guanethidine
and exposed to electrical field stimulation (EFS) and exog-
enous NO, before and in the presence of the sGC inhibitor
ODQ or the NO synthase inhibitor L-NAME. The contrac-
tile response to PGF2α did not differ between WT and KO
strips. In WT strips, EFS-induced relaxations were nearly
abolished by L-NAME and ODQ indicating that NO, act-
ing at sGC, is the neurotransmitter liberated. The
responses to EFS were greatly reduced in KO strips; in the
presence of ODQ or L-NAME, no electrically induced
relaxations were obtained. In WT strips, NO-evoked
responses were not influenced by L-NAME but reduced by
ODQ; the higher the concentration of NO, the less pro-
nounced was the inhibitory effect of ODQ. In KO strips,
NO-evoked responses were minimally reduced in com-
parison to WT strips, while the inhibitory effect of ODQ
versus NO was more pronounced. The relaxant effect of 8-
bromo-cGMP was not different between WT and KO
strips, but the relaxant effect of BAY 41-2272 was reduced
in KO strips. Cyclic guanosine monophosphate (cGMP)
levels measured at maximal relaxation by EFS or NO, were
increased 34–35 (male respectively female) fold by NO
versus basal, but were not changed by EFS in WT strips.
Basal cGMP levels were lower in KO strips, although this
did not reach significance in female mice; in KO strips NO
still induced a moderate increase in cGMP levels (3–5 fold
versus basal) but this was significantly less pronounced.
The results indicate that endogenous NO, released by EFS,
mainly acts through activation of sGCα1. The observation
that the relaxant response to exogenous NO is only mini-
mally reduced in KO strips indicates that exogenous NO
is able to act mainly through sGCα2, as the responses are
still highly sensitive to ODQ. Obviously, the subcellular
localization of cGMP raised by sGCα2 in the KO strips is
different from that by activation of sGCα1 in the WT strips,
as nearly the same degree of relaxation is induced by exog-
enous NO with a lower level of measurable cGMP.
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